We are live on
!
Find out more
Biogen
BIIB
BIIB
952 hedge funds and large institutions have $25.9B invested in Biogen in 2022 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 319 increasing their positions, 389 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
0.42% less ownership
Funds ownership: 84.25% → 83.82% (-0.42%)
1% less call options, than puts
Call options by funds: $789M | Put options by funds: $798M
6% less funds holding
Funds holding: 1,009 → 952 (-57)
12% less capital invested
Capital invested by funds: $29.6B → $25.9B (-$3.65B)
18% less repeat investments, than reductions
Existing positions increased: 319 | Existing positions reduced: 389
37% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 132
Holders
952
Holders Change
-57
Holders Change %
-5.65%
% of All Funds
15.02%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
83
Increased
319
Reduced
389
Closed
132
Calls
$789M
Puts
$798M
Net Calls
-$9.27M
Net Calls Change
+$411M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$158M |
| 2 |
Two Sigma Advisers
New York
|
+$140M |
| 3 |
Man Group
London,
United Kingdom
|
+$132M |
| 4 |
BlackRock
New York
|
+$86.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$86.3M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$513M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$112M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$111M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$109M |
| 5 |
Amundi
Paris,
France
|
-$99.2M |
